Microfluidics, electronics and inkjet technology underlie a newly developed all-in-one biochip from Stanford that can analyze cells for research and clinical applications.
Researchers at the Stanford University School of Medicine have developed a way to produce a cheap and reusable diagnostic “lab on a chip” with the help of an ordinary inkjet printer.
At a production cost of as little as 1 cent per chip, the new technology could usher in a medical diagnostics revolution like the kind brought on by low-cost genome sequencing said Ron Davis, PhD, professor of biochemistry and of genetics and director of the Stanford Genome Technology Center.
A study describing the technology was published online Feb. 6 in the Proceedings of the National Academy of Sciences. Davis is the senior author. The lead author is Rahim Esfandyarpour, PhD, an engineering research associate at the genome center.
The inexpensive lab-on-a-chip technology has the potential to enhance diagnostic capabilities around the world, especially in developing countries. Due to inferior access to early diagnostics, the survival rate of breast cancer patients is only 40 percent in low-income nations — half the rate of such patients in developed nations. Other lethal diseases, such as malaria, tuberculosis and HIV, also have high incidence and bad patient outcomes in developing countries. Better access to cheap diagnostics could help turn this around, especially as most such equipment costs thousands of dollars.
“Enabling early detection of diseases is one of the greatest opportunities we have for developing effective treatments,” Esfandyarpour said. “Maybe $1 in the U.S. doesn’t count that much, but somewhere in the developing world, it’s a lot of money.”
A two-part system
A combination of microfluidics, electronics and inkjet printing technology, the lab on a chip is a two-part system. The first is a clear silicone microfluidic chamber for housing cells and a reusable electronic strip. The second part is a regular inkjet printer that can be used to print the electronic strip onto a flexible sheet of polyester using commercially available conductive nanoparticle ink.
“We designed it to eliminate the need for clean-room facilities and trained personnel to fabricate such a device,” said Esfandyarpour, an electrical engineer by training. One chip can be produced in about 20 minutes, he said.
Designed as a multifunctional platform, one of its applications is that it allows users to analyze different cell types without using fluorescent or magnetic labels that are typically required to track cells. Instead, the chip separates cells based on their intrinsic electrical properties: When an electric potential is applied across the inkjet-printed strip, cells loaded into the microfluidic chamber get pulled in different directions depending on their “polarizability” in a process called dielectrophoresis. This label-free method to analyze cells greatly improves precision and cuts lengthy labeling processes.
The tool is designed to handle small-volume samples for a variety of assays. The researchers showed the device can help capture single cells from a mix, isolate rare cells and count cells based on cell types. The cost of these multifunctional biochips is orders of magnitude lower than that of the individual technologies that perform each of those functions. A standalone flow cytometer machine, for example, which is used to sort and count cells, costs $100,000, without taking any operational costs into account.
Potential to democratize diagnostics
“The motivation was really how to export technology and how to decrease the cost of things,” Davis said.
The low cost of the chips could democratize diagnostics similar to how low-cost sequencing created a revolution in health care and personalized medicine, Davis said. Inexpensive sequencing technology allows clinicians to sequence tumor DNA to identify specific mutations and recommend personalized treatment plans. In the same way, the lab on a chip has the potential to diagnose cancer early by detecting tumor cells that circulate in the bloodstream. “The genome project has changed the way an awful lot of medicine is done, and we want to continue that with all sorts of other technology that are just really inexpensive and accessible,” Davis said.
The technology has the potential to not only advance health care, but also to accelerate basic and applied research. It would allow scientists and clinicians to potentially analyze more cells in shorter time periods, manipulate stem cells to achieve efficient gene transfer and develop cost-effective ways to diagnose diseases, Esfandyarpour said. The team hopes the chip will create a transformation in how people use instruments in the lab. “I’m pretty sure it will open a window for researchers because it makes life much easier for them — just print it and use it,” he said.
The work is an example of Stanford Medicine’s focus on precision health, the goal of which is to anticipate and prevent disease in the healthy and precisely diagnose and treat disease in the ill.
[osd_subscribe categories=’Lab-on-a-chip-5′ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “LAB-ON-A-CHIP”‘]
Receive an email update when we add a new LAB-ON-A-CHIP article.
The Latest on: Lab-on-a-chip
[google_news title=”” keyword=”Lab-on-a-chip” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Lab-on-a-chip
- Light Field Lab raises $50M to manufacture its SolidLight holographic displayson February 8, 2023 at 5:55 am
Light Field Lab has raised $50 million to manufacture and commercialize ... But it means there are a lot of chips and wires running through the boxes. The manufacturing is quite complex. “What we’re ...
- Big Changes Ahead For Chip Technology And Industry Dynamicson February 8, 2023 at 12:01 am
What follows are excerpts of that conversation, which was held in front of a live audience at the recent SEMI Industry Strategy Symposium. To view part one of this discussion, click here. SE: What ...
- Biosensor could lead to new drugs, sensory organs on a chipon February 7, 2023 at 5:34 pm
A synthetic biosensor that mimics properties found in cell membranes and provides an electronic readout of activity could lead to a better understanding of cell biology, development of new drugs, and ...
- Arm CEO says firm fully committed to a market listing this yearon February 7, 2023 at 11:56 am
The chief executive of Softbank-owned British chip technology firm Arm told Reuters on Tuesday that the company is committed to a stock market float this year.
- Laboratorio Público / Innovaciónon February 6, 2023 at 5:00 am
El día a día de la administración pública suele tener diversas actividades. Los procesos como informes, asignación o liberación de recursos se vuelven ...
- Lab-on-a-chip (LOC) Market Outlook 2023 to 2029 Top Players - Danaher, Thermo Fisher Scientific, Roche, Abbott Laboratorieson February 5, 2023 at 11:19 am
Get Sample PDF Brochure with Full TOC, List of Tables and Figures, Chart: A PESTEL analysis is conducted for the Lab-on-a-chip (LOC) market, providing valuable insights about the regional market. The ...
- China’s Top Nuclear-Weapons Lab Used American Computer Chips Decades After Banon January 29, 2023 at 5:00 am
The state-owned institute has continued buying computer chips made by Intel and Nvidia despite its inclusion on a U.S. export blacklist in 1997.
- A Swiss sense for "Lab on a chip"on January 24, 2023 at 4:00 pm
Andreas Manz's vision of a sensor able to detect the presence of chemicals at the molecular level, known as a lab-on-a chip, is still out of reach but it does not stop researchers from trying.
- Global Lab On A Chip LOC Market Growing Status And Estimate 2023-2028on January 16, 2023 at 4:00 pm
Jan 17, 2023 (Heraldkeepers) -- An in-depth analysis of the Lab on a chip LOC market is provided in the report, which examines drivers, restraints, opportunities, and challenges. Stakeholders can ...
via Bing News